Study Of SU011248 Versus Chemotherapy For Patients With Previously Treated Triple Receptor Negative Breast Cancer
Public ClinicalTrials.gov record NCT00246571. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized Phase 2 Study Of SU011248 Versus Standard-Of-Care For Patients With Previously Treated, Advanced, Triple Receptor Negative (ER, PR, HER2) Breast Cancer
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to compare progression free survival for SU011248 \[sutent (sunitinib malate)\] versus standard of care therapy in patients with previously treated, advanced, triple receptor negative (ER, PR, HER2) locally recurrent or metastatic breast cancer.
Study identification
- NCT ID
- NCT00246571
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 217 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 2006 (Type not available)
- Primary completion
- May 2010 (Actual)
- Completion
- Jun 2011 (Actual)
- Last update posted
- Jul 12, 2012
2006 – 2011
United States locations
- U.S. sites
- 77
- U.S. states
- 18
- U.S. cities
- 62
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Pfizer Investigational Site | Corona | California | 92879 | — |
| Pfizer Investigational Site | Fullerton | California | 92835 | — |
| Pfizer Investigational Site | Glendora | California | 91741 | — |
| Pfizer Investigational Site | Los Angeles | California | 90095-1772 | — |
| Pfizer Investigational Site | Los Angeles | California | 90095-7423 | — |
| Pfizer Investigational Site | Los Angeles | California | 90095 | — |
| Pfizer Investigational Site | Mission Hills | California | 91345 | — |
| Pfizer Investigational Site | Northridge | California | 91325 | — |
| Pfizer Investigational Site | Palm Springs | California | 92262-4885 | — |
| Pfizer Investigational Site | Pasadena | California | 91105 | — |
| Pfizer Investigational Site | Pomona | California | 91767 | — |
| Pfizer Investigational Site | Rancho Cucamonga | California | 91730 | — |
| Pfizer Investigational Site | Santa Monica | California | 90404 | — |
| Pfizer Investigational Site | Valencia | California | 91355 | — |
| Pfizer Investigational Site | West Covina | California | 91790 | — |
| Pfizer Investigational Site | Aurora | Colorado | 80010 | — |
| Pfizer Investigational Site | Washington D.C. | District of Columbia | 20010 | — |
| Pfizer Investigational Site | Boca Raton | Florida | 33428 | — |
| Pfizer Investigational Site | Gainesville | Florida | 32605-4391 | — |
| Pfizer Investigational Site | Atlanta | Georgia | 30341 | — |
| Pfizer Investigational Site | Atlanta | Georgia | 30342 | — |
| Pfizer Investigational Site | Decatur | Georgia | 30033 | — |
| Pfizer Investigational Site | Macon | Georgia | 31217 | — |
| Pfizer Investigational Site | Marietta | Georgia | 30060 | — |
| Pfizer Investigational Site | Tucker | Georgia | 30084 | — |
| Pfizer Investigational Site | Zion | Illinois | 60099 | — |
| Pfizer Investigational Site | Indianapolis | Indiana | 46202 | — |
| Pfizer Investigational Site | Bloomfield Hills | Michigan | 48302 | — |
| Pfizer Investigational Site | Brownstown | Michigan | 48183 | — |
| Pfizer Investigational Site | Dearborn | Michigan | 48126 | — |
| Pfizer Investigational Site | Detroit | Michigan | 48202 | — |
| Pfizer Investigational Site | West Bloomfield | Michigan | 48322 | — |
| Pfizer Investigational Site | Biloxi | Mississippi | 39532 | — |
| Pfizer Investigational Site | Clarkson Valley | Missouri | 63011 | — |
| Pfizer Investigational Site | St Louis | Missouri | 63109 | — |
| Pfizer Investigational Site | St Louis | Missouri | 63141 | — |
| Pfizer Investigational Site | Midland Park | New Jersey | 07432 | — |
| Pfizer Investigational Site | Morristown | New Jersey | 07962 | — |
| Pfizer Investigational Site | Paramus | New Jersey | 07652 | — |
| Pfizer Investigational Site | Pompton Plains | New Jersey | 07444 | — |
| Pfizer Investigational Site | Ridgewood | New Jersey | 07450 | — |
| Pfizer Investigational Site | Summit | New Jersey | 07902 | — |
| Pfizer Investigational Site | Westwood | New Jersey | 07675 | — |
| Pfizer Investigational Site | The Bronx | New York | 10451 | — |
| Pfizer Investigational Site | The Bronx | New York | 10461 | — |
| Pfizer Investigational Site | Clinton | North Carolina | 28388 | — |
| Pfizer Investigational Site | Goldsboro | North Carolina | 27534 | — |
| Pfizer Investigational Site | Wilson | North Carolina | 27893 | — |
| Pfizer Investigational Site | Del City | Oklahoma | 73115 | — |
| Pfizer Investigational Site | Greensburg | Pennsylvania | 15601 | — |
| Pfizer Investigational Site | Hershey | Pennsylvania | 17033-0850 | — |
| Pfizer Investigational Site | Pittsburgh | Pennsylvania | 15213 | — |
| Pfizer Investigational Site | Pittsburgh | Pennsylvania | 15232-1305 | — |
| Pfizer Investigational Site | Wexford | Pennsylvania | 15090 | — |
| Pfizer Investigational Site | Memphis | Tennessee | 38104 | — |
| Pfizer Investigational Site | Memphis | Tennessee | 38120 | — |
| Pfizer Investigational Site | Memphis | Tennessee | 38133 | — |
| Pfizer Investigational Site | Dallas | Texas | 75230-2510 | — |
| Pfizer Investigational Site | Dallas | Texas | 75230 | — |
| Pfizer Investigational Site | Fort Worth | Texas | 76177 | — |
| Pfizer Investigational Site | Houston | Texas | 77024 | — |
| Pfizer Investigational Site | Houston | Texas | 77055 | — |
| Pfizer Investigational Site | Plano | Texas | 75075 | — |
| Pfizer Investigational Site | Plano | Texas | 75093 | — |
| Pfizer Investigational Site | Richardson | Texas | 75080 | — |
| Pfizer Investigational Site | San Antonio | Texas | 78207 | — |
| Pfizer Investigational Site | San Antonio | Texas | 78217 | — |
| Pfizer Investigational Site | San Antonio | Texas | 78229 | — |
| Pfizer Investigational Site | San Antonio | Texas | 78258 | — |
| Pfizer Investigational Site | San Atonio | Texas | 78229 | — |
| Pfizer Investigational Site | Tyler | Texas | 75702 | — |
| Pfizer Investigational Site | Federal Way | Washington | 98003 | — |
| Pfizer Investigational Site | Lakewood | Washington | 98499 | — |
| Pfizer Investigational Site | Puyallup | Washington | 98372 | — |
| Pfizer Investigational Site | Seattle | Washington | 98104 | — |
| Pfizer Investigational Site | Seattle | Washington | 98122 | — |
| Pfizer Investigational Site | Tacoma | Washington | 98405 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 36 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00246571, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 12, 2012 · Synced Oct 26, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00246571 live on ClinicalTrials.gov.